By proceeding, you agree to our Terms of Use and Privacy Policy.
Christopher Thompson Head, Nonclinical Safety at Decibel Therapeutics
Talks About #nonclinical
Preferred Locations #NorthAmerica
Welcome to the Optimizing AAV Safety Summit: Predict & Monitor AAV Safety Signals to De-Risk Genetic Therapy Development Hundreds of clinical trials using AAV are underway, with several hundred more in preclinical development.